Yousef Ismael
Overview
Explore the profile of Yousef Ismael including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
66
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lucas Jr J, Faught A, Hsu C, Wilson L, Guo Y, Li Y, et al.
Int J Radiat Oncol Biol Phys
. 2022 Jan;
113(1):152-160.
PMID: 34990778
Purpose: Vasculopathy (VAS) is a significant complication associated with radiation therapy in patients treated for brain tumors. We studied the type, location, severity, timing, and resolution of VAS in children...
2.
Uh J, Merchant T, Conklin H, Ismael Y, Li Y, Han Y, et al.
Int J Radiat Oncol Biol Phys
. 2020 Sep;
109(2):515-526.
PMID: 32898610
Purpose: To determine the preirradiation baseline association of white matter integrity with neurocognitive function and to assess posttreatment changes in pediatric patients with craniopharyngioma treated with proton therapy. Methods And...
3.
Raghavan K, Camfield A, Lucas J, Ismael Y, Rossi M, Anghelescu D
J Adolesc Young Adult Oncol
. 2019 Oct;
9(2):299-302.
PMID: 31644320
Radiation-induced phantosmia has been reported both in children and adults. A fraction of these patients have nausea and vomiting triggered by phantosmia. Radiation-induced phantosmia, although transient, can be distressing enough...
4.
Abdel-Razeq H, Mansour A, Abdulelah H, Al-Shwayat A, Makoseh M, Ibrahim M, et al.
Thromb J
. 2018 Mar;
16:2.
PMID: 29507532
Background: The risk of thromboembolic events is higher among cancer patients, especially in patients undergoing chemotherapy. Cisplatin-based regimens claim to be associated with a very high thromboembolic rate. In this...
5.
Abdel-Razeq H, Mansour A, Saadeh S, Abu-Nasser M, Makoseh M, Salam M, et al.
Clin Appl Thromb Hemost
. 2017 Feb;
24(3):429-433.
PMID: 28183196
Venous thromboembolism (VTE) is a commonly encountered problem in patients with cancer. In recent years, cancer treatment paradigm has shifted with most therapy offered in ambulatory outpatient settings. Excess of...
6.
Mansour A, Ismael Y, Abdel-Razeq H
Hematol Oncol Stem Cell Ther
. 2014 Oct;
7(4):136-41.
PMID: 25300564
Background: Cancer and its treatment are recognized risk factors for venous thromboembolism (VTE). Inferior vena cava (IVC) filters are utilized to provide mechanical thromboprophylaxis to prevent pulmonary embolism (PE) or...
7.
Mansour A, Ismael Y, Abunasser M, Hammode E, Turfa R, Abdel-Razeq H
Patient Prefer Adherence
. 2013 Nov;
7:1111-6.
PMID: 24187488
Introduction: Prompt diagnosis and treatment of pulmonary embolism (PE) can help reduce its associated morbidity and mortality. Computed tomography chest angiography (CTA) scanning is the most widely used diagnostic modality....
8.
Abdel-Razeq H, Ismael Y
Ther Clin Risk Manag
. 2011 Jul;
7:213-7.
PMID: 21753883
Purpose: Thrombocytopenia is not uncommonly encountered following active anticoagulation of thromboembolism with unfractionated or even low-molecular-weight heparins. In this report, and utilizing a case study, we will address issues related...
9.
Abdel-Razeq H, Mansour A, Ismael Y, Abdulelah H
Ther Clin Risk Manag
. 2011 Apr;
7:99-102.
PMID: 21479140
Purpose: Cancer and its treatment are recognized risk factors for venous thromboembolism (VTE); active cancer accounts for almost 20% of all newly diagnosed VTE. Inferior vena cava (IVC) filters are...
10.
Valentino L, Ismael Y, Grygotis M
Expert Opin Emerg Drugs
. 2010 Jul;
15(4):597-613.
PMID: 20653467
Importance Of The Field: Hemophilia management requires replacement of the deficient clotting factor. Inhibitor development complicates treatment, and the implementation of and adherence to prophylaxis, considered the standard of care...